Share this article
Share this article
BEIJING, May 5, 2021 /PRNewswire/ Recon Technology, Ltd (NASDAQ: RCON), ( Recon or the Company ), today announced the Company s subsidiary, Future Gas Station (Beijing) Technology, Ltd. ( FGS ), renewed its cooperation agreement dated March 18, 2018 (the Agreement ) with Banma Network Technology Co., Ltd. (the Banma ), an Alibaba-backed connected car company focusing on autonomous intelligent car operating system development, for three years starting from May 1, 2021.
Pursuant to the Agreement, FGS integrates its self-developed DT Refuel function with Banma s Smart Refuel application, which is embedded into Banma s vehicle system, so Banma s care users could refuel at the gas stations of Petro China Co., Ltd. ( Petro China ) through Banma s Smart Refuel. FGS and Banma aim to provide value-added services and better refueling experience to the vehicle owners through this long-term cooperation.
55 Biggest Movers From Yesterday Benzinga 2 hrs ago
Gainers
Marlin Business Services Corp. (NASDAQ: MRLN) shares surged 50.7% to close at $21.46 on Monday after the company enters into a definitive agreement to be acquired by funds managed by HPS Investment Partners for $23.50 per share in cash.
Knoll, Inc. (NYSE: KNL) rose 35.2% to settle at $23.30 after the company announced it would be acquired by Herman Miller for $11 in cash and 0.32 shares of the combined company per Knoll share owned.
China Green Agriculture, Inc. (NYSE: CGA) jumped 28.3% to settle at $16.87 after climbing over 20% on Friday.
TDH Holdings, Inc. (NASDAQ: PETZ) gained 27.8% to close at $2.71.
Recon Technology Announces FGS Cooperation Agreement with Henan CNPC and Alipay
News provided by
Share this article
Share this article
BEIJING, April 8, 2021 /PRNewswire/ Recon Technology, Ltd (NASDAQ: RCON), ( Recon or the Company ), today announced the Company s 51%-owned subsidiary, Future Gas Station (Beijing) Technology, Ltd. ( FGS ), has entered into a cooperation agreement (the Agreement ) with Henan sales branch of PetroChina Co. Ltd. ( Henan CNPC ) and Alipay (Hangzhou) Information Technology Co., Ltd ( Alipay ) to develop a mini program named Hao Ke Le Jia on Alipay s mobile application and to provide operation and maintenance services for the related joint membership program. This is the second time that FGS and Alipay cooperate since they began to provide similar service to Zhejiang sales branch of PetroChina Co. Ltd. ( Zhejiang CNPC ) in October 2020.
Share this article
Share this article
BEIJING, Jan. 19, 2021 /PRNewswire/ Recon Technology, Ltd. (NASDAQ: RCON), ( Recon or the Company ), a China-based independent solutions integrator in the oilfield service, electric power and coal chemical industries, today announced that the Company successfully completed the design and implementation of an intelligent control platform system (the System ) for North China E&P Company (the North China Branch ) of China Petroleum & Chemical Corporation ( Sinopec ), according to a technology service agreement (the Agreement ) signed between one of Recon s subsidiaries and the North China Branch of Sinopec in October 2020.
The System will help Sinopec analyze the data collected by the sensors installed on electrical submersible pumps (the ESPs ) of gas wells using AI algorithm automatically and monitor and control the operation of the ESPs according to the analysis. This is the first time that intelligent technology is used in Sinopec s
60 Stocks Moving In Thursday s Mid-Day Session Benzinga 12/10/2020
Gainers
Immutep Limited (NASDAQ: IMMP) shares jumped 198.6% to $6.42 after the company said its Chinese partner, EOC Pharma will commence a new Phase 2 clinical trial of Immutep s eftilagimod alpha in up to 152 metastatic breast cancer patients in China. Immutep said the study follows encouraging data reported by it in its APIAC Phase 2b study announced at the end of March and presented at the SABCS.
Greenwich LifeSciences, Inc. (NASDAQ: GLSI) shares surged 67.4% to $95.60. Greenwich LifeSciences shares jumped 998% on Wednesday after the company shared the poster for the GP2 Phase 2b clinical trial final efficacy analysis that was presented Wednesday at the 2020 San Antonio Breast Cancer Symposium.